Merck & Co as of Dec. 31, 2025
Portfolio Holdings for Merck & Co
Merck & Co holds 12 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Personalis Ord (PSNL) | 40.5 | $112M | 14M | 7.96 | |
| Moderna (MRNA) | 24.6 | $68M | 2.3M | 29.49 | |
| Kymera Therapeutics (KYMR) | 21.7 | $60M | 772k | 77.81 | |
| Entrada Therapeutics | 6.5 | $18M | 1.7M | 10.28 | |
| Evaxion Biotech A/s Sponsored Ads | 2.1 | $5.8M | 1.2M | 4.77 | |
| Alector (ALEC) | 2.0 | $5.5M | 3.5M | 1.56 | |
| Sutro Biopharma | 1.1 | $3.2M | 272k | 11.57 | |
| Miragen Therapeutics (VRDN) | 1.1 | $2.9M | 93k | 31.12 | |
| Xilio Therapeutics (XLO) | 0.3 | $950k | 1.5M | 0.64 | |
| Carisma Therapeutics (CARM) | 0.0 | $63k | 1.5M | 0.04 | |
| Neuphoria Therapeutics (NEUP) | 0.0 | $39k | 10k | 3.88 | |
| Tuhura Biosciences (HURA) | 0.0 | $11k | 14k | 0.76 |
